Who is the CEO of ProGen?

According to the DART company overview, ProGen's representative director is 김종균,이병화(각자 대표이사) (name as registered in Korean). The company was founded on 1998-10-21.

Where is ProGen listed?

ProGen trades on the Korea Exchange KONEX market under the ticker 296160. Its fiscal year ends in December.

Does ProGen pay a dividend?

ProGen did not pay a cash dividend for fiscal 2025, according to its annual report.

Which companies are in the same industry as ProGen?

Under the Korean Standard Industrial Classification recorded on DART, ProGen is grouped with 52 other listed companies in medical & pharmaceutical r&d. The most covered in Korean news over the past 30 days are Alteogen, Qurient and Vaxcell-Bio Therapeutics.

ProGen KRX:296160KONEX

프로젠 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days0

Articles tracked0since Sep 11

ProGen (프로젠) appeared in 0 Korean news articles and 0 DART filings over the past seven days.

ProGen top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest ProGen news Korean headlines

No articles yet.

Articles per day 2 weeks

Company profile

CEO: 김종균,이병화(각자 대표이사)
Industry: Medical & pharmaceutical R&D
Founded: 1998-10-21
Fiscal year-end: December
Head office: 서울특별시 강서구
Website: progen.co.kr
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Same industry Medical & pharmaceutical R&D

All in industry

Company	Latest quarter op. profit	Articles 30d
Alteogen	₩34.2bn	55
Qurient	−₩12.8bn	26
Vaxcell-Bio Therapeutics	−₩5.0bn	22
OliX Pharmaceuticals	−₩14.0bn	20
Penetrium Bioscience	−₩1.9bn	19
Aribiolab	−₩2.5bn	15
LigaChem Biosciences	−₩72.0bn	14
ImmuneOncia Therapeutics	−₩4.3bn	14

Compare ProGen side by side with these companies

ProGen DART filings

Sep 2315:08

Other [기재정정]주식매수선택권부여에관한신고
Other
Sep 2315:07

Other [기재정정]주식매수선택권부여에관한신고
Other
Sep 2315:05

Other [기재정정]주식매수선택권부여에관한신고
Other
Sep 1814:40

Investor relations event 기업설명회(IR)개최
Other

Mentioned alongside 2 weeks

No co-mentioned companies yet.

ProGen FAQ

Who is the CEO of ProGen?: According to the DART company overview, ProGen's representative director is 김종균,이병화(각자 대표이사) (name as registered in Korean). The company was founded on 1998-10-21.
Where is ProGen listed?: ProGen trades on the Korea Exchange KONEX market under the ticker 296160. Its fiscal year ends in December.
Does ProGen pay a dividend?: ProGen did not pay a cash dividend for fiscal 2025, according to its annual report.
Which companies are in the same industry as ProGen?: Under the Korean Standard Industrial Classification recorded on DART, ProGen is grouped with 52 other listed companies in medical & pharmaceutical r&d. The most covered in Korean news over the past 30 days are Alteogen, Qurient and Vaxcell-Bio Therapeutics.